Similar Articles
231 Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape
232 Effectiveness of transarterial chemoembolization in combination with lenvatinib and programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma
233 Maximizing therapeutic outcomes in hepatocellular carcinoma: Insights into combinatorial strategies
234 Effectiveness and safety of sequential transarterial chemoembolization and microwave ablation for subphrenic hepatocellular carcinoma: A comprehensive evaluation
235 Prognostic significance of exportin-5 in hepatocellular carcinoma
236 BCAR3 and BCAR3-related competing endogenous RNA expression in hepatocellular carcinoma and their prognostic value
237 Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma
238 Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
239 Research trends and hotspots in the immune microenvironment related to hepatocellular carcinoma: A bibliometric and visualization study
240 Predicting hepatocellular carcinoma: A new non-invasive model based on shear wave elastography
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA